| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/29/2004 | CN1533399A 免疫调节肽 Immunomodulatory peptides |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1168728C Pyrrolo-isoquinoline and tetrahydropyrrolko-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 09/29/2004 | CN1168726C Novel vitamin D analogues |
| 09/29/2004 | CN1168714C Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers |
| 09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
| 09/29/2004 | CN1168488C Chinese medicinal preparation for treating pyretic stranguria |
| 09/29/2004 | CN1168485C Medicine for treating strenguria |
| 09/28/2004 | CA2299013C Neuropeptide y antagonists |
| 09/28/2004 | CA2167268C Anti-angiogenic compositions and methods of use |
| 09/23/2004 | WO2004081001A1 Novel 2-pyridinecarboxamide derivatives |
| 09/23/2004 | WO2004080444A2 Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using cav2.2 subunit calcium channel modulators |
| 09/23/2004 | WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 09/23/2004 | US20040186299 such as 3-(3,5-dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylic acid; for lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes; for increasing leptin levels with no liver toxicity |
| 09/23/2004 | US20040186288 3,5-Diamino-1,2,4-triazoles as kinase inhibitors |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
| 09/23/2004 | US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/23/2004 | US20040186111 Therapeutic agents useful for treating pain |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 09/23/2004 | US20040186061 Novel derivatives of 3,3-diphenylpropylamines |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185122 Selective COX-2 inhibition from edible plant extracts |
| 09/22/2004 | EP1460074A1 Substituted amino alkyl compounds |
| 09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 09/22/2004 | EP1459759A1 Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
| 09/22/2004 | EP1459751A1 (S,S)-reboxetine for treating migraine headaches |
| 09/22/2004 | EP1459750A1 (S,S)-reboxetine for treating fibromyalgia and other somatoform disorders |
| 09/22/2004 | EP1459749A1 (S,S)-reboxetine for treating incontinence |
| 09/22/2004 | EP1459748A1 (S,S)-reboxetine for treating peripheral neuropathy |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458864A1 Tgf-beta-specific covalently closed antisense molecule |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/22/2004 | EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 09/22/2004 | EP1458721A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
| 09/22/2004 | EP1458717A1 Aroyl pyridinones |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458712A2 Novel compounds |
| 09/22/2004 | EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458427A2 Compositions comprising collagen and metalloprotease inhibitors |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458386A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 09/22/2004 | EP1458381A1 Triazoles as oxytocin antagonists |
| 09/22/2004 | EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/22/2004 | EP1458376A1 Darifenacin for use in the treatment of urgency induced by overactive bladder |
| 09/22/2004 | EP1274709B1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 09/22/2004 | EP1268389B1 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators |
| 09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
| 09/22/2004 | EP1140981B1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 09/22/2004 | EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 09/22/2004 | EP1054869B1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 09/22/2004 | EP1000062B1 Tricyclic vasopressin agonists |
| 09/22/2004 | EP0914119B1 Process for forming solid oral dosage forms of valsartan |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531550A Heterocarpine, human GHRH-binding protein |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 09/22/2004 | CN1531429A Medicament, containing effector of glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1530366A Sulphonic acid amide for regulating bast peptide activity and derivative thereof |
| 09/22/2004 | CN1530127A Oral preparation for nourishing kidney and treating chronic prostatitis |
| 09/22/2004 | CN1530100A Food containing Angelica sinensis extractive and medicine composition thereof |
| 09/22/2004 | CN1167670C Aryl carboxylic acid and tetrazole derivant |
| 09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794403 Substituted benzoxazoles as estrogenic agents |
| 09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
| 09/21/2004 | US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/21/2004 | US6794361 Conotoxin polypeptide inhibits neuronal amine transporters; incontinence, cardiovascular disorders |
| 09/16/2004 | WO2004078784A1 Novel gene relating to fibrotic conditions |
| 09/16/2004 | WO2004078212A1 Medicinal composition for regulating release and process for producing the same |
| 09/16/2004 | WO2004078104A2 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
| 09/16/2004 | WO2004056380A3 Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation |
| 09/16/2004 | WO2003105776A3 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 09/16/2004 | WO2003105666A3 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 09/16/2004 | WO2003104253A3 9-alpha-substituted estratrienes as selectively active estrogen |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003045228A9 Methods for treating autoimmune disorders, and reagents related thereto |
| 09/16/2004 | WO2002050097A3 Anti-allergic complex molecules |
| 09/16/2004 | US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/16/2004 | US20040181062 Benzimidazole cyclooxygenase-2 inhibitor |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040180962 Dosage forms having prolonged active ingredient release |
| 09/16/2004 | US20040180952 Derivatives of (-)- and (+)-venlafaxine and methods of preparing and using the same |
| 09/16/2004 | US20040180944 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
| 09/16/2004 | US20040180890 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/16/2004 | US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists |